Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11352)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2016 (publication date) through Dec 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takai E, Yachida S. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. World J Gastroenterol 2016; 22(38): 8480-8488 [PMID: 27784960 DOI: 10.3748/wjg.v22.i38.8480] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i38/8480.htm |
| Number | Citing Articles |
| 1 |
Gahee Park, Joo Kyung Park, Dae-Soon Son, Seung-Ho Shin, Yeon Jeong Kim, Hyo-Jeong Jeon, Jae Lee, Woong-Yang Park, Kwang Hyuck Lee, Donghyun Park. Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30100-w
|
| 2 |
Shun Wang, Yan Zheng, Feng Yang, Le Zhu, Xiao-Qiang Zhu, Zhe-Fang Wang, Xiao-Lin Wu, Cheng-Hui Zhou, Jia-Yan Yan, Bei-Yuan Hu, Bo Kong, De-Liang Fu, Christiane Bruns, Yue Zhao, Lun-Xiu Qin, Qiong-Zhu Dong. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy 2021; 6(1) doi: 10.1038/s41392-021-00659-4
|
| 3 |
Rav Sellahewa, Samar Masoumi Moghaddam, Joanne Lundy, Brendan J. Jenkins, Daniel Croagh. Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer. Pancreas 2023; 52(3): e188 doi: 10.1097/MPA.0000000000002239
|
| 4 |
L. Sivapalan, H.M. Kocher, H. Ross-Adams, C. Chelala. Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application. Pancreatology 2021; 21(2): 363 doi: 10.1016/j.pan.2020.12.017
|
| 5 |
Shweta Khanna, Prasanta Padhan, Sourav Das, Kumar Sagar Jaiswal, Archana Tripathy, Shuchi Smita, Suraj K. Tripathy, Sunil Kumar Raghav, Bhawna Gupta. A Simple Colorimetric Method for Naked‐Eye Detection of Circulating Cell‐Free DNA Using Unlabelled Gold Nanoparticles. ChemistrySelect 2018; 3(41): 11541 doi: 10.1002/slct.201802671
|
| 6 |
Mohamadmahdi Samandari, María Gil Julia, Alistair Rice, Antonios Chronopoulos, Armando E. del Rio Hernandez. Liquid biopsies for management of pancreatic cancer. Translational Research 2018; 201: 98 doi: 10.1016/j.trsl.2018.07.008
|
| 7 |
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala, Radek Kroupa, Petr Kysela, Jiri Dolina, Jan Trna. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5389820
|
| 8 |
Takahiro Kishikawa, Minoru Tada, Motoyuki Otsuka, Kazuhiko Koike. Biomarkers in Cancer Therapy. 2019; : 97 doi: 10.1007/978-981-13-7295-7_9
|
| 9 |
Yasunori Uesato, Naoki Sasahira, Masato Ozaka, Takashi Sasaki, Mitsuhisa Takatsuki, Hitoshi Zembutsu, Jung Weon Lee. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis. PLOS ONE 2020; 15(7): e0235623 doi: 10.1371/journal.pone.0235623
|
| 10 |
Narshone Soda, Kimberley Clack, Muhammad J. A. Shiddiky. Recent advances in liquid biopsy technologies for cancer biomarker detection. Sensors & Diagnostics 2022; 1(3): 343 doi: 10.1039/D2SD00010E
|
| 11 |
Shasha Guan, Guochao Deng, Jingjie Sun, Quanli Han, Yao Lv, Tianhui Xue, Lijuan Ding, Tongxin Yang, Niansong Qian, Guanghai Dai. Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.926260
|
| 12 |
Chen Lin, Xuzhu Liu, Bingyi Zheng, Rongqin Ke, Chi-Meng Tzeng. Liquid Biopsy, ctDNA Diagnosis through NGS. Life 2021; 11(9): 890 doi: 10.3390/life11090890
|
| 13 |
Yuyan Xu, Jianpeng Cai, Kaihang Zhong, Yaohong Wen, Lei Cai, Guolin He, Hangyu Liao, Cheng Zhang, Shunjun Fu, Tingting Chen, Jinping Cai, Xuefeng Zhong, Chunzhu Chen, Mengli Huang, Yuan Cheng, Mingxin Pan. Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1119744
|
| 14 |
Hideyuki Hayashi, Shigeki Tanishima, Kyoko Fujii, Ryo Mori, Yasunobu Okamura, Emmy Yanagita, Ryosuke Matsuoka, Toraji Amano, Ichiro Kinoshita, Yoshito Komatsu, Hirotoshi Dosaka-Akita, Hiroshi Nishihara. Genomic testing for pancreatic cancer in clinical practice as real-world evidence. Pancreatology 2018; 18(6): 647 doi: 10.1016/j.pan.2018.07.006
|
| 15 |
Songbo Xie, Yuhan Wu, Huijie Hao, Jingrui Li, Song Guo, Wei Xie, Dengwen Li, Jun Zhou, Jinmin Gao, Min Liu. CYLD deficiency promotes pancreatic cancer development by causing mitotic defects. Journal of Cellular Physiology 2019; 234(6): 9723 doi: 10.1002/jcp.27658
|
| 16 |
Clare Fiala, Vathany Kulasingam, Eleftherios P Diamandis. Circulating Tumor DNA for Early Cancer Detection. The Journal of Applied Laboratory Medicine 2018; 3(2): 300 doi: 10.1373/jalm.2018.026393
|
| 17 |
Narshone Soda, Bernd H. A. Rehm, Prashant Sonar, Nam-Trung Nguyen, Muhammad J. A. Shiddiky. Advanced liquid biopsy technologies for circulating biomarker detection. Journal of Materials Chemistry B 2019; 7(43): 6670 doi: 10.1039/C9TB01490J
|
| 18 |
Jessy Abraham, Sunita Singh, Shalaka Joshi. Liquid biopsy - emergence of a new era in personalized cancer care. Applied Cancer Research 2018; 38(1) doi: 10.1186/s41241-018-0053-0
|
| 19 |
Karolina Elżbieta Kaczor-Urbanowicz, Jordan Cheng, Jonathan C. King, Alireza Sedarat, Stephen J. Pandol, James J. Farrell, David T.W. Wong, Yong Kim. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers. Pancreas 2020; 49(9): 1141 doi: 10.1097/MPA.0000000000001662
|
| 20 |
Lena Gorgannezhad, Muhammad Umer, Md. Nazmul Islam, Nam-Trung Nguyen, Muhammad J. A. Shiddiky. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Lab on a Chip 2018; 18(8): 1174 doi: 10.1039/C8LC00100F
|
| 21 |
Andreas W. Berger, Thomas Seufferlein. „Liquid biopsy“ in der gastrointestinalen Onkologie: Hype oder bald Realität?. Journal für Gastroenterologische und Hepatologische Erkrankungen 2022; 20(2): 45 doi: 10.1007/s41971-022-00129-w
|
| 22 |
E. Giovannetti, D. Massihnia, N. Barraco, A. Listì, L. Incorvaia, M. Castiglia, Antonio Russo. Liquid Biopsy in Cancer Patients. Current Clinical Pathology 2017; : 137 doi: 10.1007/978-3-319-55661-1_15
|
| 23 |
Hideyuki HAYASHI. Clinical sequencing of pancreatic cancer in clinical practice. Suizo 2018; 33(6): 915 doi: 10.2958/suizo.33.915
|
| 24 |
Amin El-Heliebi, Ellen Heitzer. Nucleic Acid Nanotheranostics. 2019; : 133 doi: 10.1016/B978-0-12-814470-1.00005-8
|
| 25 |
Junya Tsuboi, Reiko Yamada, Yoshifumi S. Hirokawa. Biomarkers in Cancer Detection and Monitoring of Therapeutics. 2024; : 151 doi: 10.1016/B978-0-323-95114-2.00016-9
|
| 26 |
Alex José de Melo‐Silva, Jessica Paula Lucena, Thomas Hueneburg. The evolution of molecular diagnosis using digital polymerase chain reaction to detect cancer via cell‐free DNA and circulating tumor cells. Cell Biology International 2020; 44(3): 735 doi: 10.1002/cbin.11286
|
| 27 |
Manuela Krumbholz, Johanna Eiblwieser, Andreas Ranft, Jakob Zierk, Christian Schmidkonz, Adrian M Stütz, Peter Peneder, Eleni M. Tomazou, Abbas Agaimy, Tobias Bäuerle, Wolfgang Hartmann, Uta Dirksen, Markus Metzler. Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma. Clinical Cancer Research 2021; 27(21): 5922 doi: 10.1158/1078-0432.CCR-21-1324
|
| 28 |
Lukas M. Braun, Simon Lagies, Jessica Guenzle, Stefan Fichtner-Feigl, Uwe A. Wittel, Bernd Kammerer. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines. Cells 2020; 9(5): 1251 doi: 10.3390/cells9051251
|
| 29 |
Lukas M. Braun, Simon Lagies, Rhena F. U. Klar, Saskia Hussung, Ralph M. Fritsch, Bernd Kammerer, Uwe A. Wittel. Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures. Cancers 2020; 12(6): 1440 doi: 10.3390/cancers12061440
|
| 30 |
Simon Lagies, Manuel Schlimpert, Lukas M. Braun, Michel Kather, Johannes Plagge, Thalia Erbes, Uwe A. Wittel, Bernd Kammerer. Unraveling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry. Analytical and Bioanalytical Chemistry 2019; 411(24): 6319 doi: 10.1007/s00216-019-01814-1
|
| 31 |
Mansi Gupta, Pravin Potdar. Significance of Liquid Biopsy Containing Circulating Tumor DNA (ctDNA) Analysis for Evaluation and Management of Metastatic Cancer. Diseases and Research 2023; 3(1): 22 doi: 10.54457/DR.202301003
|
| 32 |
Katsutoshi Shoda, Daisuke Ichikawa, Yuji Fujita, Kiyoshi Masuda, Hidekazu Hiramoto, Junichi Hamada, Tomohiro Arita, Hirotaka Konishi, Toshiyuki Kosuga, Shuhei Komatsu, Atsushi Shiozaki, Kazuma Okamoto, Issei Imoto, Eigo Otsuji. Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer. Oncotarget 2017; 8(17): 28796 doi: 10.18632/oncotarget.15675
|
| 33 |
Joseph R. Habib, Lingdi Yin, Jun Yu. Pancreatic ductal adenocarcinoma: the role of circulating tumor DNA. Journal of Pancreatology 2019; 2(3): 72 doi: 10.1097/JP9.0000000000000021
|
| 34 |
Claudio Luchini, Nicola Veronese, Alessia Nottegar, Vera Cappelletti, Maria G. Daidone, Lee Smith, Christopher Parris, Lodewijk A. A. Brosens, Maria G. Caruso, Liang Cheng, Christopher L. Wolfgang, Laura D. Wood, Michele Milella, Roberto Salvia, Aldo Scarpa. Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine. Cancers 2019; 11(8): 1152 doi: 10.3390/cancers11081152
|
| 35 |
I. V. Mikhailov, V. N. Beliakouski, V. A. Kudrashou, A. P. Dyatlov, Ch. A.A.D. Weerakoon. Biopsy of pancreatic tumors prior to resection: for and against. Health and Ecology Issues 2021; (1): 62 doi: 10.51523/2708-6011.2021-18-1-9
|
| 36 |
Shin-E Wang, Bor-Uei Shyr, Bor-Shiuan Shyr, Shih-Chin Chen, Shih-Ching Chang, Yi-Ming Shyr. Circulating Cell-Free DNA in Pancreatic Head Adenocarcinoma Undergoing Pancreaticoduodenectomy. Pancreas 2021; 50(2): 214 doi: 10.1097/MPA.0000000000001730
|
| 37 |
Niklas Sturm, Thomas J. Ettrich, Lukas Perkhofer. The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers 2022; 14(1): 217 doi: 10.3390/cancers14010217
|